
    
      Subjects will be followed through a course of FORTEO therapy for up to 24 months and for an
      additional 24 months after FORTEO treatment is stopped. Subjects may participate in this
      study for up to 48 months. All aspects of patient care, including diagnostic and therapeutic
      interventions, will be chosen and conducted at the discretion of the participating study
      physician according to their clinical judgment and the local standard of medical care.
    
  